| EEF1G |
EEF1G, EF1G, PRO1608: Elongation factor 1-gamma |
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
4.55 |
Evidence |
|
| NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
4.55 |
Evidence |
|
| NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
4.55 |
Evidence |
|
| NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
4.55 |
Evidence |
|
| MCM3 |
MCM3: DNA replication licensing factor MCM3 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
4.55 |
Evidence |
|
| MCM3 |
MCM3: DNA replication licensing factor MCM3 |
FZR1 |
IPI00099464 |
4.55 |
Evidence |
|
| MCM3 |
MCM3: DNA replication licensing factor MCM3 |
HIST1H3A |
HIST1H3A, H3FA, HIST1H3B, H3FL, HIST1H3C, H3FC, HIST1H3D, H3FB, HIST1H3E, H3FD, |
4.55 |
Evidence |
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
4.55 |
Evidence |
|
| POLR2A |
POLR2A: Uncharacterized protein POLR2A |
TOP3A |
TOP3A, TOP3: DNA topoisomerase 3-alpha |
4.55 |
Evidence |
|
| POLR2A |
POLR2A: Uncharacterized protein POLR2A |
BLM |
BLM, RECQ2, RECQL3: Bloom syndrome protein |
4.55 |
Evidence |
|
| DDX5 |
DDX5, G17P1, HELR, HLR1: Probable ATP-dependent RNA helicase DDX5 |
RELA |
RELA, NFKB3: Transcription factor p65 |
4.55 |
Evidence |
|
| CTPS |
CTPS: CTP synthase 1 |
PIK4CB |
PIK4CB, RP11-126K1.4-003, hCG_1811976: Phosphatidylinositol 4-kinase, catalytic, |
4.55 |
Evidence |
|
| CSDA |
CSDA, DBPA: DNA-binding protein A |
CDK2 |
CDK2: Cell division protein kinase 2 |
4.55 |
Evidence |
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
4.55 |
Evidence |
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
COPA |
COPA: Coatomer subunit alpha |
4.55 |
Evidence |
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
TMEM1 |
TMEM1, EHOC1: Transmembrane protein 1 |
4.55 |
Evidence |
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
ZNF76 |
ZNF76, D6S229E: Zinc finger protein 76 |
4.55 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
CFL1 |
CFL1, CFL: Cofilin-1 |
4.55 |
Evidence |
|
| BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
RPA2 |
RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit |
4.55 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
4.55 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
RPA2 |
RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit |
4.55 |
Evidence |
|
| SRF |
SRF: Serum response factor |
CREBBP |
CREBBP, CBP: CREB-binding protein |
4.55 |
Evidence |
|
| SRF |
SRF: Serum response factor |
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
4.55 |
Evidence |
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
PKN2 |
PKN2, PRK2, PRKCL2: Serine/threonine-protein kinase N2 |
4.55 |
Evidence |
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
CDK6 |
CDK6: Cell division protein kinase 6 |
4.55 |
Evidence |
O
|